These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36434879)

  • 1. Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies.
    De Aquino JP; Bahji A; Gómez O; Sofuoglu M
    Drug Alcohol Depend; 2022 Dec; 241():109702. PubMed ID: 36434879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs.
    Lake S; Kerr T; Buxton J; Walsh Z; Cooper ZD; Socías ME; Fairbairn N; Hayashi K; Milloy MJ
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):155-165. PubMed ID: 34813374
    [No Abstract]   [Full Text] [Related]  

  • 3. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
    Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
    CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.
    Babalonis S; Walsh SL
    Eur Neuropsychopharmacol; 2020 Jul; 36():206-216. PubMed ID: 32273144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.
    De Aquino JP; Meyerovich J; Xie CZ; Ranganathan M; Compton P; Pittman B; Rogan M; Sofuoglu M
    Addict Biol; 2023 Sep; 28(9):e13317. PubMed ID: 37644897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.
    Nutt DJ; Phillips LD; Barnes MP; Brander B; Curran HV; Fayaz A; Finn DP; Horsted T; Moltke J; Sakal C; Sharon H; O'Sullivan SE; Williams T; Zorn G; Schlag AK
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):482-500. PubMed ID: 33998895
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
    Hempel B; Xi ZX
    Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
    Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
    BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH; Fisher J; Martin BR
    Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.
    Wolkowicz NR; Sofuoglu M; Pittman B; Meyerovich J; MacLean RR; De Aquino JP
    J Psychiatr Res; 2024 Sep; 177():90-95. PubMed ID: 38991269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapies for cannabis dependence.
    Nielsen S; Gowing L; Sabioni P; Le Foll B
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD008940. PubMed ID: 30687936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums.
    Meacham MC; Nobles AL; Tompkins DA; Thrul J
    PLoS One; 2022; 17(2):e0263583. PubMed ID: 35134074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
    Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
    Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.